Unless Congress closes a loophole in the orphan drug law, new products containing the opioid addiction treatment buprenorphine could be blocked from the market until 2024.
Diagnoses of mental health and substance use disorders associated with three times higher odds of overdose.
As the opioid crisis unfolded, prescriptions for the narcotic alternative saw a two-fold increase despite unclear evidence of benefit for pain.
U-M Pediatrician: Government Missed Opportunity to Improve Care for Children With Sickle Cell Disease
Despite efforts to improve the standard of care for children with sickle cell disease, the nation falls short, says pediatrician
Insurance records reveal patterns of opioid prescribing to patients whose family members “shop” for opioids from multiple sources
Few people with HDHPs proactively ask about or search for lower-cost care. This suggests opportunity for insurers, employers and health care providers to help.